author_facet Ormanns, Steffen
Haas, Michael
Baechmann, Sibylle
Remold, Anna
Quietzsch, Detlef
Clemens, Michael R.
Bentz, Martin
Schoppmeyer, Konrad
Kruger, Stephan
Kirchner, Thomas
Heinemann, Volker
Boeck, Stefan Hubert
Ormanns, Steffen
Haas, Michael
Baechmann, Sibylle
Remold, Anna
Quietzsch, Detlef
Clemens, Michael R.
Bentz, Martin
Schoppmeyer, Konrad
Kruger, Stephan
Kirchner, Thomas
Heinemann, Volker
Boeck, Stefan Hubert
author Ormanns, Steffen
Haas, Michael
Baechmann, Sibylle
Remold, Anna
Quietzsch, Detlef
Clemens, Michael R.
Bentz, Martin
Schoppmeyer, Konrad
Kruger, Stephan
Kirchner, Thomas
Heinemann, Volker
Boeck, Stefan Hubert
spellingShingle Ormanns, Steffen
Haas, Michael
Baechmann, Sibylle
Remold, Anna
Quietzsch, Detlef
Clemens, Michael R.
Bentz, Martin
Schoppmeyer, Konrad
Kruger, Stephan
Kirchner, Thomas
Heinemann, Volker
Boeck, Stefan Hubert
Journal of Clinical Oncology
Impact of SPARC expression level on outcome in patients with advanced pancreatic cancer not receiving nab-paclitaxel: A pooled analysis from prospective clinical and translational trials.
Cancer Research
Oncology
author_sort ormanns, steffen
spelling Ormanns, Steffen Haas, Michael Baechmann, Sibylle Remold, Anna Quietzsch, Detlef Clemens, Michael R. Bentz, Martin Schoppmeyer, Konrad Kruger, Stephan Kirchner, Thomas Heinemann, Volker Boeck, Stefan Hubert 0732-183X 1527-7755 American Society of Clinical Oncology (ASCO) Cancer Research Oncology http://dx.doi.org/10.1200/jco.2015.33.15_suppl.e15264 Impact of SPARC expression level on outcome in patients with advanced pancreatic cancer <i>not</i> receiving nab-paclitaxel: A pooled analysis from prospective clinical and translational trials. Journal of Clinical Oncology
doi_str_mv 10.1200/jco.2015.33.15_suppl.e15264
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxNS4zMy4xNV9zdXBwbC5lMTUyNjQ
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxNS4zMy4xNV9zdXBwbC5lMTUyNjQ
institution DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
imprint American Society of Clinical Oncology (ASCO), 2015
imprint_str_mv American Society of Clinical Oncology (ASCO), 2015
issn 0732-183X
1527-7755
issn_str_mv 0732-183X
1527-7755
language English
mega_collection American Society of Clinical Oncology (ASCO) (CrossRef)
match_str ormanns2015impactofsparcexpressionlevelonoutcomeinpatientswithadvancedpancreaticcancernotreceivingnabpaclitaxelapooledanalysisfromprospectiveclinicalandtranslationaltrials
publishDateSort 2015
publisher American Society of Clinical Oncology (ASCO)
recordtype ai
record_format ai
series Journal of Clinical Oncology
source_id 49
title Impact of SPARC expression level on outcome in patients with advanced pancreatic cancer not receiving nab-paclitaxel: A pooled analysis from prospective clinical and translational trials.
title_unstemmed Impact of SPARC expression level on outcome in patients with advanced pancreatic cancer not receiving nab-paclitaxel: A pooled analysis from prospective clinical and translational trials.
title_full Impact of SPARC expression level on outcome in patients with advanced pancreatic cancer not receiving nab-paclitaxel: A pooled analysis from prospective clinical and translational trials.
title_fullStr Impact of SPARC expression level on outcome in patients with advanced pancreatic cancer not receiving nab-paclitaxel: A pooled analysis from prospective clinical and translational trials.
title_full_unstemmed Impact of SPARC expression level on outcome in patients with advanced pancreatic cancer not receiving nab-paclitaxel: A pooled analysis from prospective clinical and translational trials.
title_short Impact of SPARC expression level on outcome in patients with advanced pancreatic cancer not receiving nab-paclitaxel: A pooled analysis from prospective clinical and translational trials.
title_sort impact of sparc expression level on outcome in patients with advanced pancreatic cancer <i>not</i> receiving nab-paclitaxel: a pooled analysis from prospective clinical and translational trials.
topic Cancer Research
Oncology
url http://dx.doi.org/10.1200/jco.2015.33.15_suppl.e15264
publishDate 2015
physical e15264-e15264
description
container_issue 15_suppl
container_start_page 0
container_title Journal of Clinical Oncology
container_volume 33
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792325639446986759
geogr_code not assigned
last_indexed 2024-03-01T12:08:48.585Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Impact+of+SPARC+expression+level+on+outcome+in+patients+with+advanced+pancreatic+cancer+not+receiving+nab-paclitaxel%3A+A+pooled+analysis+from+prospective+clinical+and+translational+trials.&rft.date=2015-05-20&genre=article&issn=1527-7755&volume=33&issue=15_suppl&pages=e15264-e15264&jtitle=Journal+of+Clinical+Oncology&atitle=Impact+of+SPARC+expression+level+on+outcome+in+patients+with+advanced+pancreatic+cancer+%3Ci%3Enot%3C%2Fi%3E+receiving+nab-paclitaxel%3A+A+pooled+analysis+from+prospective+clinical+and+translational+trials.&aulast=Boeck&aufirst=Stefan+Hubert&rft_id=info%3Adoi%2F10.1200%2Fjco.2015.33.15_suppl.e15264&rft.language%5B0%5D=eng
SOLR
_version_ 1792325639446986759
author Ormanns, Steffen, Haas, Michael, Baechmann, Sibylle, Remold, Anna, Quietzsch, Detlef, Clemens, Michael R., Bentz, Martin, Schoppmeyer, Konrad, Kruger, Stephan, Kirchner, Thomas, Heinemann, Volker, Boeck, Stefan Hubert
author_facet Ormanns, Steffen, Haas, Michael, Baechmann, Sibylle, Remold, Anna, Quietzsch, Detlef, Clemens, Michael R., Bentz, Martin, Schoppmeyer, Konrad, Kruger, Stephan, Kirchner, Thomas, Heinemann, Volker, Boeck, Stefan Hubert, Ormanns, Steffen, Haas, Michael, Baechmann, Sibylle, Remold, Anna, Quietzsch, Detlef, Clemens, Michael R., Bentz, Martin, Schoppmeyer, Konrad, Kruger, Stephan, Kirchner, Thomas, Heinemann, Volker, Boeck, Stefan Hubert
author_sort ormanns, steffen
container_issue 15_suppl
container_start_page 0
container_title Journal of Clinical Oncology
container_volume 33
description
doi_str_mv 10.1200/jco.2015.33.15_suppl.e15264
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxNS4zMy4xNV9zdXBwbC5lMTUyNjQ
imprint American Society of Clinical Oncology (ASCO), 2015
imprint_str_mv American Society of Clinical Oncology (ASCO), 2015
institution DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229
issn 0732-183X, 1527-7755
issn_str_mv 0732-183X, 1527-7755
language English
last_indexed 2024-03-01T12:08:48.585Z
match_str ormanns2015impactofsparcexpressionlevelonoutcomeinpatientswithadvancedpancreaticcancernotreceivingnabpaclitaxelapooledanalysisfromprospectiveclinicalandtranslationaltrials
mega_collection American Society of Clinical Oncology (ASCO) (CrossRef)
physical e15264-e15264
publishDate 2015
publishDateSort 2015
publisher American Society of Clinical Oncology (ASCO)
record_format ai
recordtype ai
series Journal of Clinical Oncology
source_id 49
spelling Ormanns, Steffen Haas, Michael Baechmann, Sibylle Remold, Anna Quietzsch, Detlef Clemens, Michael R. Bentz, Martin Schoppmeyer, Konrad Kruger, Stephan Kirchner, Thomas Heinemann, Volker Boeck, Stefan Hubert 0732-183X 1527-7755 American Society of Clinical Oncology (ASCO) Cancer Research Oncology http://dx.doi.org/10.1200/jco.2015.33.15_suppl.e15264 Impact of SPARC expression level on outcome in patients with advanced pancreatic cancer <i>not</i> receiving nab-paclitaxel: A pooled analysis from prospective clinical and translational trials. Journal of Clinical Oncology
spellingShingle Ormanns, Steffen, Haas, Michael, Baechmann, Sibylle, Remold, Anna, Quietzsch, Detlef, Clemens, Michael R., Bentz, Martin, Schoppmeyer, Konrad, Kruger, Stephan, Kirchner, Thomas, Heinemann, Volker, Boeck, Stefan Hubert, Journal of Clinical Oncology, Impact of SPARC expression level on outcome in patients with advanced pancreatic cancer not receiving nab-paclitaxel: A pooled analysis from prospective clinical and translational trials., Cancer Research, Oncology
title Impact of SPARC expression level on outcome in patients with advanced pancreatic cancer not receiving nab-paclitaxel: A pooled analysis from prospective clinical and translational trials.
title_full Impact of SPARC expression level on outcome in patients with advanced pancreatic cancer not receiving nab-paclitaxel: A pooled analysis from prospective clinical and translational trials.
title_fullStr Impact of SPARC expression level on outcome in patients with advanced pancreatic cancer not receiving nab-paclitaxel: A pooled analysis from prospective clinical and translational trials.
title_full_unstemmed Impact of SPARC expression level on outcome in patients with advanced pancreatic cancer not receiving nab-paclitaxel: A pooled analysis from prospective clinical and translational trials.
title_short Impact of SPARC expression level on outcome in patients with advanced pancreatic cancer not receiving nab-paclitaxel: A pooled analysis from prospective clinical and translational trials.
title_sort impact of sparc expression level on outcome in patients with advanced pancreatic cancer <i>not</i> receiving nab-paclitaxel: a pooled analysis from prospective clinical and translational trials.
title_unstemmed Impact of SPARC expression level on outcome in patients with advanced pancreatic cancer not receiving nab-paclitaxel: A pooled analysis from prospective clinical and translational trials.
topic Cancer Research, Oncology
url http://dx.doi.org/10.1200/jco.2015.33.15_suppl.e15264